Acting FDA Chief Janet Woodcock Ruled Out as Biden Nominee
- Woodcock faced backlash over controversial Alzheimer’s drug
- She can remain as acting commissioner at least until November
This article is for subscribers only.
President Joe Biden’s administration has ruled out nominating Janet Woodcock as permanent head of the Food and Drug Administration, people familiar with the matter say, as the search continues for a leader during a crucial period for full approval of coronavirus vaccines.
Woodcock, who has served as acting commissioner since Biden took office, has faced firm opposition on Capitol Hill for the job from lawmakers including Democratic Senator Joe Manchin, a key swing vote in the evenly divided chamber who criticized the agency over the controversial accelerated approval this year of an Alzheimer’s drug.